EUR 13.06
(1.08%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 428.71 Million EUR | 18.67% |
2022 | 361.27 Million EUR | 15.44% |
2021 | 312.96 Million EUR | 0.32% |
2020 | 311.95 Million EUR | 10.41% |
2019 | 282.55 Million EUR | 9.77% |
2018 | 257.4 Million EUR | 8.85% |
2017 | 236.48 Million EUR | -28.07% |
2016 | 328.77 Million EUR | 21.61% |
2015 | 270.35 Million EUR | 22.57% |
2014 | 220.57 Million EUR | 3.8% |
2013 | 212.51 Million EUR | -3.89% |
2012 | 221.1 Million EUR | -6.98% |
2011 | 237.69 Million EUR | -38.67% |
2010 | 387.59 Million EUR | 16.53% |
2009 | 332.6 Million EUR | 0.0% |
2008 | 332.6 Million EUR | 55.53% |
2007 | 213.84 Million EUR | 25.6% |
2006 | 170.25 Million EUR | 25.1% |
2005 | 136.09 Million EUR | -27.94% |
2004 | 188.87 Million EUR | -25.4% |
2003 | 253.2 Million EUR | -6.89% |
2002 | 271.94 Million EUR | 6.64% |
2001 | 255.01 Million EUR | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | 206.45 Million EUR | 0.0% |
2023 FY | 428.71 Million EUR | 18.67% |
2023 Q4 | 259.29 Million EUR | 0.0% |
2023 Q2 | 169.41 Million EUR | 0.0% |
2022 Q4 | 201.23 Million EUR | 0.0% |
2022 Q2 | 160.03 Million EUR | 0.0% |
2022 FY | 361.27 Million EUR | 15.44% |
2021 Q4 | 175.78 Million EUR | 0.0% |
2021 FY | 312.96 Million EUR | 0.32% |
2021 Q2 | 137.18 Million EUR | 0.0% |
2020 Q2 | 109.73 Million EUR | 0.0% |
2020 Q4 | 202.22 Million EUR | 0.0% |
2020 FY | 311.95 Million EUR | 10.41% |
2019 FY | 282.55 Million EUR | 9.77% |
2019 Q2 | 102.81 Million EUR | 0.0% |
2019 Q4 | 179.73 Million EUR | 0.0% |
2018 Q2 | 90.35 Million EUR | 0.0% |
2018 FY | 257.4 Million EUR | 8.85% |
2017 FY | 236.48 Million EUR | -28.07% |
2017 Q2 | 151.61 Million EUR | 0.0% |
2016 Q4 | 183.64 Million EUR | 0.0% |
2016 FY | 328.77 Million EUR | 21.61% |
2016 Q2 | 145.12 Million EUR | 0.0% |
2015 Q2 | 120.99 Million EUR | 0.0% |
2015 Q4 | 149.36 Million EUR | 0.0% |
2015 FY | 270.35 Million EUR | 22.57% |
2014 Q2 | 98.15 Million EUR | 0.0% |
2014 FY | 220.57 Million EUR | 3.8% |
2013 Q4 | 115.13 Million EUR | 0.0% |
2013 FY | 212.51 Million EUR | -3.89% |
2013 Q2 | 97.37 Million EUR | 0.0% |
2012 FY | 221.1 Million EUR | -6.98% |
2012 Q4 | 53.12 Million EUR | -3.89% |
2012 Q3 | 55.27 Million EUR | 0.0% |
2012 Q2 | 55.27 Million EUR | 0.0% |
2012 Q1 | 55.27 Million EUR | 0.0% |
2011 Q2 | 59.42 Million EUR | 0.0% |
2011 Q4 | 55.27 Million EUR | -6.98% |
2011 FY | 237.69 Million EUR | -38.67% |
2011 Q3 | 59.42 Million EUR | 0.0% |
2011 Q1 | 59.42 Million EUR | 0.0% |
2010 Q3 | 96.89 Million EUR | 0.0% |
2010 FY | 387.59 Million EUR | 16.53% |
2010 Q4 | 59.42 Million EUR | -38.67% |
2010 Q1 | 96.89 Million EUR | 0.0% |
2010 Q2 | 96.89 Million EUR | 0.0% |
2009 FY | 332.6 Million EUR | 0.0% |
2009 Q3 | 83.15 Million EUR | 0.0% |
2009 Q2 | 83.15 Million EUR | 0.0% |
2009 Q4 | 96.89 Million EUR | 16.53% |
2009 Q1 | 83.15 Million EUR | 0.0% |
2008 FY | 332.6 Million EUR | 55.53% |
2008 Q4 | 83.15 Million EUR | 0.0% |
2008 Q3 | 83.15 Million EUR | 0.0% |
2008 Q2 | 83.15 Million EUR | 0.0% |
2008 Q1 | 83.15 Million EUR | 0.0% |
2007 Q4 | 83.15 Million EUR | 55.53% |
2007 FY | 213.84 Million EUR | 25.6% |
2007 Q1 | 53.46 Million EUR | 0.0% |
2007 Q2 | 53.46 Million EUR | 0.0% |
2007 Q3 | 53.46 Million EUR | 0.0% |
2006 FY | 170.25 Million EUR | 25.1% |
2006 Q4 | 53.46 Million EUR | 25.6% |
2006 Q2 | 42.56 Million EUR | 0.0% |
2006 Q1 | 42.56 Million EUR | 0.0% |
2006 Q3 | 42.56 Million EUR | 0.0% |
2005 Q2 | 34.02 Million EUR | 0.0% |
2005 Q3 | 34.02 Million EUR | 0.0% |
2005 FY | 136.09 Million EUR | -27.94% |
2005 Q4 | 42.56 Million EUR | 25.1% |
2005 Q1 | 34.02 Million EUR | 0.0% |
2004 Q2 | 47.21 Million EUR | 0.0% |
2004 Q4 | 34.02 Million EUR | -27.94% |
2004 FY | 188.87 Million EUR | -25.4% |
2004 Q1 | 47.21 Million EUR | 0.0% |
2004 Q3 | 47.21 Million EUR | 0.0% |
2003 Q1 | 63.3 Million EUR | 0.0% |
2003 Q4 | 47.21 Million EUR | -25.4% |
2003 Q2 | 63.3 Million EUR | 0.0% |
2003 Q3 | 63.3 Million EUR | 0.0% |
2003 FY | 253.2 Million EUR | -6.89% |
2002 Q4 | 63.3 Million EUR | -6.89% |
2002 Q3 | 67.98 Million EUR | 0.0% |
2002 Q1 | 67.98 Million EUR | 0.0% |
2002 Q2 | 67.98 Million EUR | 0.0% |
2002 FY | 271.94 Million EUR | 6.64% |
2001 FY | 255.01 Million EUR | 0.0% |
2001 Q4 | 67.98 Million EUR | 6.64% |
2001 Q3 | 63.75 Million EUR | 0.0% |
2001 Q1 | 63.75 Million EUR | 0.0% |
2001 Q2 | 63.75 Million EUR | 0.0% |
2000 Q4 | 63.75 Million EUR | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Affluent Medical SA | 1.22 Million EUR | -34925.899% |
Bluelinea Société Anonyme | 9826.00 EUR | -4362987.726% |
Carmat SA | 2.84 Million EUR | -14953.265% |
Diagnostic Medical Systems S.A. | 42.15 Million EUR | -917.05% |
Euromedis Groupe | 37.42 Million EUR | -1045.425% |
Eurobio Scientific Société anonyme | 130.64 Million EUR | -228.152% |
Ikonisys S.A. | 448.55 Thousand EUR | -95476.928% |
Implanet S.A. | 7.44 Million EUR | -5656.909% |
Median Technologies SA | 22.22 Million EUR | -1828.899% |
SpineGuard SA | 4.31 Million EUR | -9840.577% |
Theraclion SA | 1.82 Million EUR | -23427.168% |
Euroapi S.A. | 1.01 Billion EUR | 57.924% |
Guerbet SA | 785.69 Million EUR | 45.434% |
Koninklijke Philips N.V. | 18.16 Billion EUR | 97.64% |
Sequana Medical NV | 712.17 Thousand EUR | -60098.435% |